Search Within

Philip Wayne Kantoff

Formats
  1. Journal Article (118)
  2. Meeting Abstract (71)
  3. Review (4)
  4. Correspondence (2)
  5. Editorial (2)
  6. Research Letter (1)
Groups
  1. Department of Medicine (198)
  2. Genitourinary Oncology Service (198)
  3. Solid Tumor Oncology Division (198)
  4. Sloan Kettering Institute Postdocs (71)
  5. GSK Faculty (26)
  6. Human Oncology and Pathogenesis Program (23)

More Groups

People
  1. Konrad Stopsack (44)
  2. Goutam Chakraborty (29)
  3. Ying Mazzu (29)
  4. Subhiksha Nandakumar (27)
  5. Michael Morris (26)
  6. Yuki Yoshikawa (23)

More People

Years
  1. 2025 (4)
  2. 2024 (6)
  3. 2023 (3)
  4. 2022 (14)
  5. 2021 (19)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (17)
  3. Cancer Research (16)
  4. Cancer (9)
  5. Cancer Epidemiology Biomarkers and Prevention (8)
  6. European Urology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (62)
  2. American Association for Cancer Research (46)
  3. Nature Publishing Group (16)
  4. Oxford University Press (11)
  5. Wiley Blackwell (11)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acupuncture versus cognitive behavioral therapy for insomnia in cancer survivors: A randomized clinical trial
    Journal Article

    Garland, S. N.; Xie, S. X.; DuHamel, K.; Bao, T.; Li, Q.; Barg, F. K.; Song, S.; Kantoff, P.; Gehrman, P.; Mao, J. J.
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancer
    Journal Article

    Higano, C. S.; Armstrong, A. J.; Sartor, A. O.; Vogelzang, N. J.; Kantoff, P. W.; McLeod, D. G.; Pieczonka, C. M.; Penson, D. F.; Shore, N. D.; Vacirca, J.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)
    Meeting Abstract

    Taplin, M. E.; Gleave, M.; Evans, C. P.; Efstathiou, E.; Kantoff, P. W.; Ross, A.; Shore, N. D.; Briganti, A.; Hadaschik, B. A.; Heidenreich, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC): Final PROCEED analysis
    Meeting Abstract

    Sartor, A. O.; Armstrong, A. J.; Ahaghotu, C.; McLeod, D. G.; Cooperberg, M. R.; Penson, D. F.; Kantoff, P. W.; Vogelzang, N. J.; Hussain, A.; Pieczonka, C. M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes
    Meeting Abstract

    Mota, J. M.; Barnett, E.; Nauseef, J.; Stopsack, K. H.; Wibmer, A. G.; Danila, D. C.; Rathkopf, D. E.; Slovin, S. F.; Kantoff, P. W.; Scher, H. I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Targeting checkpoint kinases in prostate cancer cells resistant to poly ADP-ribose polymerase inhibitors
    Meeting Abstract

    Atiq, M. O.; Chakraborty, G.; Nandakumar, S.; Mazzu, Y. Z.; Stopsack, K. H.; Jehane, L. E.; Yoshikawa, Y.; Khan, N.; Lee, G. S. M.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Experience with sipuleucel-T in metastatic castration-resistant prostate cancer (mCRPC) with visceral spread from PROCEED
    Meeting Abstract

    Vogelzang, N. J.; Kantoff, P. W.; Scholz, M. C.; Vacirca, J. L.; Dakhil, S. R.; Goel, S.; Harmon, M.; Tang, H.; Brown, B.; Armstrong, A. J.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Time to PSA nadir and the risk of death from prostate cancer following radiation and androgen deprivation therapy
    Meeting Abstract

    Pike, L. R. G.; Wu, J.; Chen, M. H.; Loffredo, M.; Renshaw, A. A.; Pfail, J.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Methylation-associated miR193b silencing activates master drivers of aggressive prostate cancer
    Meeting Abstract

    Mazzu, Y. Z.; Chakraborty, G.; Yoshikawa, Y.; Nandakuma, S.; Armenia, J.; Jehane, L. E.; Lee, G. S. M.; Mucci, L.; Kantoff, P. W.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Immuno-genomic detection and prognostication of aggressive prostate cancer phenotypes by next-generation RNA sequencing
    Meeting Abstract

    Kassis, A. I.; Henao, R.; Wojno, K. J.; Erickson, G.; Stylli, H.; Kantoff, P. W.
    Cancer Research (2019)

    Fulltext@MSK | Save